Fenwick & West Represents goBalto in $12M Series B Financing

January 01, 2013

Fenwick & West LLP represented goBalto, Inc., developer of next-generation, cloud-based solutions that simplify how clinical trials are conducted in the pharmaceutical, biotechnology and medical device industries, in its recently announced $12 million Series B financing. The transaction was led by EDBI, with participation from existing investors Aberdare Ventures, West Health Investment Fund, Founding CEO Jae Chung and new investor Qualcomm Life Fund (managed by Qualcomm Ventures). The new round of funding brings goBalto’s total financing to $21 million to date.

The company plans on using these funds to help support the demands of growing clinical research market by developing its platform for clinical study with new product capabilities. More information about goBalto’s $12 million Series B financing can be obtained from the company press release.

The Fenwick transaction team was led by corporate partner Michael Esquivel; corporate associates Dawn Belt and Lara Muller; and technology transaction associate Stefano Quintini.